Track MPS Pharmaa Ltd.'s current share price, historical price chart, 52-week high/low, and performance across different time periods.
1 Week returns: 0.00 %
Low
2.1
High
2.1
1 Month returns: 4.52 %
Low
2.1
High
2.1
1 Year returns: 0.00 %
Low
1.6
High
2.1
3 Year CAGR: -7.89 %
Low
1.6
High
4.3
5 Year CAGR: 11.48 %
Low
1.2
High
4.3
Note: Prices may be delayed by a few minutes. For historical calculations, prices are adjusted for splits, bonus and rights issue. Percentage change shown is absolute irrespective of the period.
Multi-year trends for MPS Pharmaa Ltd. covering revenue, net profit, ROE, and EBITDA for a quick view of financial health over time.
MPS Pharmaa Ltd. Shareholding Pattern
Quarterly breakdown of MPS Pharmaa Ltd. ownership including promoter, FII, DII, mutual fund, and public holdings as disclosed to NSE/BSE.
Bulk, Block and Insider Trades
Recent bulk deals, block deals, and insider trading activity in MPS Pharmaa Ltd. shares as reported to NSE and BSE.
Frequently Asked Questions
What is the current share price of MPS Pharmaa Ltd.?
The current share price of MPS Pharmaa Ltd. is ₹ 2.08 as of 5 Oct 2026.
What is the market capitalisation of MPS Pharmaa Ltd.?
The market capitalisation of MPS Pharmaa Ltd. stands at ₹ 3.98 Cr.
What is the PE ratio of MPS Pharmaa Ltd.?
The Price-to-Earnings (PE) ratio of MPS Pharmaa Ltd. is - as of the latest trailing twelve months data.
What is the ROE and ROCE of MPS Pharmaa Ltd.?
MPS Pharmaa Ltd. has a Return on Equity (ROE) of - and a Return on Capital Employed (ROCE) of - as per the latest financial reports.
What is the 52-week high and low of MPS Pharmaa Ltd.?
The 52-week high of MPS Pharmaa Ltd. is - and the 52-week low is -.
What is the dividend yield of MPS Pharmaa Ltd.?
The dividend yield of MPS Pharmaa Ltd. is - based on the current market price.
What is the FII and DII holding in MPS Pharmaa Ltd.?
Foreign Institutional Investors (FII) hold 0.00%, Domestic Institutional Investors (DII) hold 0.00% and retail/public investors hold 38.68% of MPS Pharmaa Ltd. shares.
What sector does MPS Pharmaa Ltd. belong to?
MPS Pharmaa Ltd. operates in the Healthcare sector.
What is the beta of MPS Pharmaa Ltd.?
The beta of MPS Pharmaa Ltd. is 0.01, indicating its price volatility relative to the broader market.
What is the RSI of MPS Pharmaa Ltd.?
The 14-day Relative Strength Index (RSI) of MPS Pharmaa Ltd. is 68.03, placing it approaching overbought territory. An RSI above 70 is considered overbought and below 30 is considered oversold.
Stock Analysis
Fundamental analysis overview of MPS Pharmaa Ltd. covering key investment insights, growth drivers, risk factors, and potential red flags.
Views
Red Flags
Positive
Not enough talking points with positive stance
Negative
Stock is fairly expensive with negative EPS on a trailing 12-month basis
Earnings yield of nan% indicates that the stock is very expensive and has a negative EPS on a trailing 12-month basis
What is Earnings yield (E/P)?
Neutral
Not enough talking points with neutral stance
Stock in GSM list
The stock has been places in Graded Surveillance Measure (GSM) list (GSM - IV).
Thinly traded (low daily turnover)
The stock is thinly traded with combined (NSE & BSE) daily turnover (21-day average) of 0.00123106.
Company Profile
Overview of MPS Pharmaa Ltd. covering business description, industry classification, key management, financial ratios, and listed exchange details.
MPS Pharmaa Limited is engaged in the manufacturing, marketing, trading, and export of pharmaceutical products. The Company provides various pharmaceutical medicines, such as anti-allergic capsules, anti-allergic tablets, anti-inflammatory tablets, anti-inflammatory capsules, antihypertensives, analgesic, antipyretic, pharmaceutical formulations, and anti-inflammatory, antibacterial and antibiotics. In addition, the Company exports a range of drugs to a number of countries worldwide. Its generic products include Cefadroxil Tablets USP, Cefalexin Capsules BP, Ciprofloxacin Tablets USP, Doxycycline Capsules B.P., Amoxiciilin Capsules B.P., Azithromycin Capsules USP., Floncip, Mezonal Tablets, Ampicillin Capsules B.P., Metronidazole Tablets BP, Cotrimoxazole tablets B.P, Norfloxacin Tablets USP, Griseofulvin tablets BP, and more. Its ethical products include Chewfe-C, Stibomin, Arfa Gel, Majispa, Twosum, Robial, Wibatol-O, and Wibatol. It has its own manufacturing facility at Sohna.
MPS Pharmaa Limited is engaged in the manufacturing, marketing, trading, and export of pharmaceutical products. The Company provides various pharmaceutical medicines, such as anti-allergic capsules, anti-allergic tablets, anti-inflammatory tablets, anti-inflammatory capsules, antihypertensives, anal...